1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 1.15M | - |
| Gross profit | 147.2K | - |
| Net profit | -1.34M | 258.77% |
| EBITDA | -1.35M | 257.63% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €19.13M |
Number of shares | 21.41M |
52-week high/low | €1.67 - €0.44 |
| Dividends | No |
Beta | 0.50 |
P/E ratio | -2.52 |
PEG ratio | 0.02 |
P/B ratio | 11.49 |
P/S ratio | 5.94 |
Company profile
U.S. NeuroSurgical Holdings, Inc. besitzt und betreibt über seine Tochtergesellschaften Zentren für stereotaktische Radiochirurgie, die die Gamma Knife-Technologie einsetzen. Das Gamma Knife ist ein stereotaktisches radiochirurgisches Gerät, das zur Behandlung von Hirntumoren und anderen Fehlbildungen des Gehirns ohne invasive Operation eingesetzt wird. U.S. NeuroSurgical Holdings, Inc. wurde 1993 gegründet und hat seinen Sitz in Rockville, Maryland.
| Name | US NEUR |
| CEO | Jeereddi Anjaneya Prasad |
| Headquarters | Ontario,
md USA |
| Website | |
| Sector | Utilities |
| Industry | Health Care Providers & Services |
| IPO | 07/14/2009 |
| Employees | 3 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Pnk | USNU |
Discover assets
Shareholders of US NEUR also invest in the following assets
